Jorgensen Nathan D.
- SEC CIK
- 0001842523
In the past year, 2 open-market sale filings worth $54.2K and no purchases.
Current role at each company
- VYGR Voyager Therapeutics, Inc.Chief Financial Officeras of Feb 26, 2026
- VOR Vor Biopharma Inc.CHIEF FINANCIAL OFFICERas of May 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $54.2K
- 2 filings
- Net
- −$54.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jorgensen Nathan D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VYGR Voyager Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 (view filing) | Feb 24 | 2 days | Jorgensen Nathan D.Chief Financial Officer | SSale | −4.67K | $3.77 | −$17.6K | −3.0%151.4K after | 10b5-1 |
| Oct 7, 2025 (view filing) | Oct 3 | 4 days | Jorgensen Nathan D.Chief Financial Officer | SSale | −7.67K | $4.78 | −$36.6K | −5.8%123.8K after | 10b5-1 |